跳至主要内容
临床试验/CTRI/2026/01/100273
CTRI/2026/01/100273尚未招募3 期

Boladi vati and Rajapravartini vati in the Management of Udavartini Yonivyapad With Special Refrance to Dysmenorrhea

Dr Twinkle varshney1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年1月13日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Improvement in Intensity of Pain and Duration of Pain

研究概览

简要总结

Udavartini yonivyapad is described in modern science as dysmenorrhea, which is more prevalent in young adolescent girls and reproductive aged women . The incidence of dysmenorrhoea is affected generally by social status, occupation and age.

Dysmenorrhoea literally means painful menstruation of sufficient magnitude so as to incapacitate day to day activities

According to Ayurveda, it is type of yonivyapad which is characterized by pain and difficult expulsion of menstrual blood due to upward movement of raja ( menstrual blood) propelled by vitiated vata. The upward movement is called as Udavrittam. Due to movement of flatus, natural urge in reversible direction, the aggravated Apana vayu moving in reverse direction vitiate yoni. Apana vayu dushit yoni seized the pain, initially throws or pushes the raja upwards, then discharge it with great difficulty. The suffering patient feels relief immediately following discharge of menstrual blood. Hence this condition of raja moves upward or in reverse direction is termed as Udavartini. Besides painful and frothy menstruation, there are other pains of vata

According to Ayurveda the major cause of Udavartini is prakupitta vata with viloma gati and thus vata shaman with prakruta gati anuloma gati will solve the problem. Most women experience minor pain during menstruation, dysmenorrhea is diagnosed when the pain is so severe as to limit normal activities. Spasmodic dysmenorrhea can be severe enough to require medication7. Hence the women experiences excessive pain during menstrual cycle. Pain may be accompanied by nausea, vomiting, headaches, and fainting.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • patient with chief complaint of painful menstruation at least two consecutive cycles without pelvic pathology.

排除标准

  • Patients having Pelvic inflammatory disorder.
  • Patients having anatomical or uterine pathology, fibroid, adenomyosis, cervical stenosis, endometriosis, DUB, Endometrial Polyp etc.
  • Patients suffering from Diabetes, HTN, Thyroid disorder.
  • Patient taking hormonal therapy or IUCD in uterus.
  • Congenital anomalies of reproductive system.
  • PCOD and other medical, surgical, Neurological conditions resulting dysmenorrhoea.

结局指标

主要结局

Improvement in Intensity of Pain and Duration of Pain

时间窗: 3 Months | The Trail Drug Will be Given for 3 months with Anupana and follow Up Will be After every Menstrual Cycle

次要结局

  • Relief in Vomiting Tenderness & Headache(After Analyzing all the Parameters the Result Will be Assessed on the basis of Symptomatic Relief & Improvement)

研究者

发起方
Dr Twinkle varshney
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Twinkle varshney

Jeevan Jyoti medical college and hopital lodha aligarh

研究点 (1)

Loading locations...

相似试验